Molecular modeling yields new antiestrogenic and antitumor antineoplaston A10 analogues July 22, 1999
EntreMed signs manufacturing agreement for Angiostatin in preparation for phase I trials July 21, 1999
Phase II trial results in colorectal and lung cancers support efficacy and tolerability of S-1 July 21, 1999
RSS